Amanote Research
Register
Sign In
TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?
doi 10.20944/preprints201809.0040.v1
Full Text
Open PDF
Abstract
Available in
full text
Date
September 3, 2018
Authors
Kouassi T. Kouassi
Palanikumar Gunasekar
Devendra K. Agrawal
Gopal Jadhav
Publisher
MDPI AG
Related search
TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma
Haematologica
Hematology
Is Pseudoexfoliation Syndrome a Risk Factor for Cardiovascular Diseases?
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Endoplasmic Reticulum Stress: A Novel Mechanism and Therapeutic Target for Cardiovascular Diseases
Acta Pharmacologica Sinica
Medicine
Pharmacology
NO Is Pivotal in Motor Pathologies, but Is It Harmful or Protective?
Is TRPV1 a Useful Target in Respiratory Diseases?
Pulmonary Pharmacology and Therapeutics
Biochemistry
Medicine
Pulmonary
Respiratory Medicine
Pharmacology
The Role of Gene TREM-1 at Children Who Have Operation Congenital Heart Diseases
Translational Medicine
Pivotal Studies of Orphan Drugs Approved for Neurological Diseases
Annals of Neurology
Neurology
Ghrelin as a Treatment for Cardiovascular Diseases
Hypertension
Internal Medicine
The Thymus Is a Common Target Organ in Infectious Diseases
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics